weight loss

Doctors are warning that people taking GLP-1 weight-loss and diabetes drugs such as Ozempic face heightened health risks during the current heat wave. The drugs can contribute to dehydration, and patients may not feel thirsty or may experience nausea and vomiting, making it harder to stay hydrated. Medical experts are advising users to drink water regularly, avoid excessive heat, and seek medical attention if they develop dizziness or other symptoms of dehydration.

Mexico's national team lost to the United States, a result drawing wide attention across Mexico, Spain and the US. ESPN México reports that coach Jaime Lozano-era analyst Márquez's project remains unaffected by the defeat, arguing the loss does not undermine the team's longer-term development plan despite the rivalry's emotional weight for fans.

Patients taking Ozempic and similar GLP-1 weight-loss and diabetes drugs are reporting nail problems, adding to earlier complaints of hair loss. The reports have surfaced as use of the medications surges worldwide, and users are swapping accounts of brittle, damaged or abnormal nails. It remains unclear whether the drugs directly cause the nail changes or whether rapid weight loss and nutritional shifts are responsible, and regulators have not established a confirmed link.

Researchers report that three days of fasting triggers systemic changes across the body, according to findings covered by ScienceDaily and picked up by news outlets. The study suggests the effects extend well beyond weight loss, with broad physiological shifts emerging only after the 72-hour mark. The findings are prompting discussion about what prolonged fasting actually does to human health.

GLP-1 drugs like Ozempic and Wegovy are changing shopping habits, and retailers are taking notice. Users report reduced appetite and smaller grocery baskets, prompting stores and food companies to reassess portions, product mixes, and marketing. Industry analysts say the shift could reshape demand across food, snack, and apparel categories as adoption of the weight-loss drugs keeps growing.

Nutritionist Ayesha Nasir has released an October diet plan aimed at helping people lose weight, drawing strong engagement online. The plan lays out eating guidance for the month under the promise that viewers can finally shed excess pounds. It is circulating widely among audiences interested in nutrition and seasonal weight-loss routines.

The municipal council of Katwijk in the Netherlands has approved a building plan for a large American diet pill factory, reportedly belonging to pharmaceutical company Eli Lilly. The facility would produce popular weight-loss injections such as Zepbound or Mounjaro, and the decision is drawing local attention over its scale and impact on the region.

Italian health coverage is converging on blood sugar and cardiovascular risk. New research shows stress can send glucose test results sharply higher, while commentators stress that GLP-1 weight-loss drugs are not enough without proper nutrition education. It comes as the European Commission launches its first EU Screening Week from Milan and issues new recommendations to member states, with cardiovascular diseases causing 1.7 million deaths a year in Europe.

Novo Nordisk has received approval in Singapore for Wegovy as the first treatment for MASH, a liver disease involving fibrosis. It marks a new indication for the weight-loss drug beyond obesity and diabetes. Attention centres on how semaglutide could expand into treating fatty liver disease globally.

Dr Sean O'Mara, a physician and attorney focused on health and performance, has published what he calls the only carnivore diet guide you will ever need, laying out the all-meat eating approach in full. The guide has drawn over 130,000 likes as interest in meat-only diets for weight loss and performance continues to grow, alongside ongoing debate among nutrition experts about the diet's safety and long-term effects.

Researchers have published new findings on how a full week of fasting affects the human body. The work is drawing attention to the physical changes that occur during prolonged fasting, a topic of growing public interest as intermittent and extended fasting gain popularity for weight loss and health.

Brazilian health outlets are publishing advice on managing blood glucose levels before breakfast, recommending simple morning habits to add to daily routines. The topic coincides with renewed attention on weight-loss injections, as a study on retatrutide showed participants losing up to 23.4% of their body weight, keeping blood sugar and metabolic health in the public conversation.

Retailer GIANT has broadened its nutrition and pharmacy services for customers using GLP-1 weight-loss and diabetes medications. The expanded support is aimed at helping shoppers manage diet and medication needs as demand for GLP-1 drugs continues to grow across the retail pharmacy sector.

New research suggests fat cells can retain a 'memory' of obesity, which may help explain why losing weight and keeping it off is so difficult. According to the reporting, adipose cells appear to carry epigenetic changes established during weight gain, altering how they function even after weight loss. The findings are drawing attention in science and health circles, with discussion focused on what this means for obesity treatment and the biology of yo-yo dieting.

Personal trainer Kylie Balis has outlined four common fitness habits she stopped doing in order to lose 7kg while keeping her strength. Writing in Women's Health, she says the changes were sustainable rather than extreme, allowing her to stay strong as she lost weight. Her advice is drawing attention from readers looking for realistic, trainer-backed weight-loss guidance.

Trenton-area columnist Jeff Edlestein reflects on what a home means once the people and moments that filled it are gone, arguing that a house still holds meaning as a keeper of memories even after its residents have moved on or passed away. The piece is a sentimental, personal essay rather than a market story, touching on family, loss and the emotional weight of real estate.

Tirzepatide, the injectable drug sold as Mounjaro, is being discussed after a Guardian report described it as the 'Godzilla' of weight-loss drugs, saying it could provide other important health benefits beyond shedding pounds. Researchers are examining whether the medication, which targets two gut hormones, may also improve conditions such as heart and metabolic disease.

EatingWell has published a roundup of 15 easy high-fiber breakfast ideas aimed at supporting weight loss. The list highlights simple morning meals built around fiber-rich foods, which help keep people fuller for longer. It is part of ongoing seasonal interest in practical diet tips, with readers looking for quick, healthy breakfast options that fit busy routines and weight-management goals.

Novo Nordisk is lowering the price of its weight-loss drug Wegovy by 20 percent in Sweden, according to multiple Swedish business and news outlets. The move comes as GLP-1 medicines, once marketed primarily as obesity treatments for patients, are increasingly described in industry coverage as lifestyle drugs competing for customers, intensifying pressure on pricing.

A major clinical trial has found that diet drinks are just as effective as water for weight loss, challenging the common belief that artificially sweetened beverages undermine dieting efforts. Participants who consumed diet drinks lost weight comparably to those drinking water. Nutrition researchers say the findings could change guidance for people trying to cut calories while still enjoying sweet-tasting beverages.

Danone has developed a new drink targeting consumers taking weight loss medications such as GLP-1 drugs, according to a report carried by Polish Radio. The product is aimed at people whose reduced appetite on these treatments creates demand for nutrient-dense foods and drinks. The move reflects how major food companies are adapting product lines to the rapid rise of anti-obesity medication use worldwide.

Lizzo's physical transformation is drawing widespread attention, with coverage focusing on how she achieved it through exercise, changes to her nutrition, and a new daily routine. The story frames her weight loss as the result of sustained lifestyle changes rather than a quick fix, and it is generating discussion about her health, body image, and public expectations of the singer.

A Medium essay titled 'On Being Fat' by author J. Cafesin is circulating on social media, tagged across health, obesity, dieting and exercise topics. The piece addresses overweight, denial and the realities of weight loss, and is being shared amid ongoing holiday-season discussion about food, fitness and body health.

Scientists behind GLP-1 weight-loss and diabetes drugs are among the favourites as Nobel Prize week begins, with bookmakers and commentators tipping the work for the medicine prize. The drugs' global impact on obesity treatment has fuelled expectations the researchers will be recognised when the awards are announced.

Rachael Ray, the American television cook and talk show host, is being discussed over noticeable changes in her appearance, with fans commenting on her weight loss across recent years. Coverage focuses on what Ray herself has said about her health and fitness approach, including her outlook on diet, exercise and lifestyle, rather than any single dramatic announcement from the celebrity chef.

Reba McEntire's name is being attached to a so-called morning weight loss trick involving baking soda and lemon water, driving a wave of searches about the drink and the country star's figure. There is no confirmation the singer uses or endorses the mixture, and health experts have long warned that baking soda drinks do not cause fat loss.

A new study suggests children taking GLP-1 weight-loss and diabetes drugs may be at risk of nutritional deficiencies. The findings raise concerns about how appetite suppression and reduced food intake from medications like Ozempic and Wegovy could affect growing bodies, adding to the ongoing debate over the safety of prescribing these drugs to young patients.

Giant Co., the US grocery retailer, is broadening its well-being services tailored to customers using GLP-1 weight-loss medications. The expanded offerings are aimed at supporting shoppers on drugs like Ozempic and Wegovy with nutrition guidance and related in-store and pharmacy resources. The move reflects how grocers are racing to serve the fast-growing population of Americans taking GLP-1 treatments.

A new GLP-1 drug is under scrutiny as commentators ask whether it is a genuine medical advance or an overhyped product with unproven safety. GLP-1 medications, already widely used for diabetes and weight loss, have surged in popularity, and each new entrant prompts questions about side effects, long-term risks and who should take them. Coverage so far frames the drug as part of an ongoing debate rather than reporting confirmed safety problems.